Wealthfront Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,069
| Closed | -$288K | – | 966 |
|
|
2025
Q1 | $288K | Buy |
+4,069
| New | +$288K | ﹤0.01% | 851 |
|
|
2024
Q4 | – | Sell |
-30,188
| Closed | -$2.12M | – | 916 |
|
|
2024
Q3 | $2.12M | Sell |
30,188
-619
| -2% | -$43.5K | 0.01% | 486 |
|
|
2024
Q2 | $2.54M | Buy |
30,807
+3,619
| +13% | +$298K | 0.01% | 430 |
|
|
2024
Q1 | $2.37M | Sell |
27,188
-2,648
| -9% | -$231K | 0.01% | 445 |
|
|
2023
Q4 | $2.88M | Buy |
29,836
+6,591
| +28% | +$636K | 0.01% | 372 |
|
|
2023
Q3 | $2.06M | Sell |
23,245
-5,763
| -20% | -$510K | 0.01% | 418 |
|
|
2023
Q2 | $2.51M | Sell |
29,008
-15,342
| -35% | -$1.33M | 0.01% | 373 |
|
|
2023
Q1 | $4.31M | Buy |
44,350
+21,347
| +93% | +$2.08M | 0.02% | 235 |
|
|
2022
Q4 | $2.38M | Buy |
23,003
+16,727
| +267% | +$1.73M | 0.01% | 364 |
|
|
2022
Q3 | $532K | Buy |
6,276
+3,620
| +136% | +$307K | ﹤0.01% | 588 |
|
|
2022
Q2 | $220K | Buy |
+2,656
| New | +$220K | ﹤0.01% | 744 |
|